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Abstract
Background: We analyzed placental DNA methylation levels at repeated sequences (LINE1 elements) and all CCGG
sites (the LUMA assay) to study the effect of modifiable clinical or laboratory procedures involved in in vitro
fertilization. We included four potential modifiable factors: oxygen tension during embryo culture, fresh embryo
transfer vs frozen embryo transfer, intracytoplasmic sperm injection (ICSI) vs conventional insemination or day 3
embryo transfer vs day 5 embryo transfer.
Results: Global methylation levels differed between placentas from natural conceptions compared to placentas
conceived by IVF. Placentas from embryos cultured at 20% oxygen showed significant differences in LINE1
methylation compared to in vivo conceptions, while those from embryos cultured at 5% oxygen, did not have
significant differences. In addition, placentas from fresh embryo transfer had significantly different LINE1 methylation
compared to placentas from in vivo conceptions, while embryos resulting from frozen embryos were not
significantly different from controls. On sex-stratified analysis, only males had significant methylation differences at
LINE1 elements stratified for the modifiable factors. As expected, LINE1 methylation was significantly different
between males and females in the control population. However, we did not observe sex-specific differences in the
IVF group. We validated this sex-specific observation in an additional cohort and in opposite sex IVF twins.
Conclusion: We show that two clinically modifiable factors (embryo culture in 5 vs 20% oxygen tension and fresh
vs frozen embryo transfer) are associated with global placental methylation differences. Interestingly, males appear
more vulnerable to such treatment-related global changes in DNA methylation than do females.
Keywords: Methylation, Modifiable factors, IVF, Oxygen tension, Fresh transfer, Frozen transfer, LINE1
Background
Assisted reproductive technologies (ART) have been as-
sociated with multiple epigenetic changes including al-
teration in DNA methylation in both the placenta and
the offspring [1–7]. Several explanations have been pro-
posed as contributing to the etiology of these changes,
including infertility itself, superovulation, in vitro
fertilization (IVF), gamete/embryo manipulation, and
embryo culture [8, 9]. We have recently demonstrated,
using an analysis of placentas from donor oocyte
recipients, that site-specific DNA methylation differences
observed between ARTand in vivo conceptions are associ-
ated, at least in part, with the ART procedure itself, and
not the underlying infertility [10]. Animal studies have
confirmed that multiple techniques utilized during IVF
may play a role in these methylation changes [11–19].
Collectively, these observations suggest strongly that
some of the clinical or laboratory procedures used in
ART are responsible for altering DNA methylation levels
at multiple sites in the genome. Given this likelihood, we
chose to compare modifications of several ART proce-
dures, individually, for an association with DNA methyla-
tion differences. The clinical and laboratory procedures
compared were embryo culture in 5 vs 20% O2, fresh em-
bryo transfer vs frozen embryo transfer, intracytoplasmic
sperm injection (ICSI) vs conventional insemination and
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day 3 embryo transfer vs day 5 embryo transfer. We used
surrogate measures of genome-wide DNA methylation as
biomarkers of whether exposure to individual clinical or
laboratory protocols used in ART might alter epigenetic
marks in the placenta. The rationale behind using mea-
sures of methylation level that are averaged over
hundreds-of-thousands-to-millions of CpG sites rather
than methylation levels at specific sites is that a surrogate
genome-wide average is more likely to be representative
of the degree to which a particular factor is capable of dis-
rupting epigenetic marks. In addition, multi-site methyla-
tion differences that are cumulative and observed between
groups stratified on the basis of particular exposures are
more likely to be reproducible than differences at individ-
ual sites because the exposures being investigated are not
hypothesized to have effects that are targeted at specific
CpGs. Moreover, the collection of CpGs usually interro-
gated by site-specific, array-based profiling methods are
highly-selected and enriched for gene promoters and gene
bodies. Interrogating methylation levels at repeated se-
quences that make up a large fraction of the human gen-
ome or all sites recognized by a particular restriction
endonuclease is more likely to be representative of the gen-
ome, as a whole, than even large numbers of CpG sites se-
lected to be within or adjacent to coding sequences. Finally,
searching for procedure-specific, site-specific methylation
differences using array-based epigenome-wide profiling
methods requires significant statistical penalties because of
the requirement of correction for multiple testing.
The aim of this study was to analyze the placental
DNA methylation levels at repeated sequences (LINE1
elements) and all CCGG sites (the LUMA assay) to study
the effect of modifiable clinical or laboratory procedures
involved in in vitro fertilization. We included four potential
modifiable factors: oxygen tension during embryo culture,
fresh embryo transfer vs frozen embryo transfer, intracyto-
plasmic sperm injection (ICSI) vs conventional insemin-
ation or day 3 embryo transfer vs day 5 embryo transfer.
Methods
Samples and clinical protocols
The present study was approved by the University of
Pennsylvania Institutional Review Board (approval num-
ber 804530). Placentas were acquired from live-born de-
liveries resulting from IVF pregnancies and naturally
conceived pregnancies (controls). For IVF pregnancies,
all patients had undergone in vitro fertilization at Penn
Fertility Care (between 2006–2012 for original cohort
and 2013 onwards for validation cohort) using standard
protocols. Superovulation was performed using recom-
binant or purified-urinary follicle stimulating hormone
and/or human menopausal gonadotropin. Gonadotropin
dose was chosen based on patient characteristics and
was adjusted during stimulation as clinically indicated
based on patient response. Oocyte maturation was in-
duced with human chorionic gonadotropin or leuprolide
acetate followed by transvaginal egg retrieval 35–36 h
later. Fertilization, by intracytoplasmic sperm injection
(ICSI) was performed for either male factor or unex-
plained infertility as clinically indicated. Conventional
insemination or ICSI and embryo culture were performed
utilizing appropriate media (VitroLife; Gothenburg,
Sweden) in microdroplets under oil in either 20% oxygen
tension (5% CO2 in air) or 5% oxygen tension (5% O2, 5%
CO2, and 90% N2), and transferred to the uterus on either
day 3 (cleavage) or day 5 (blastocyst) of embryo develop-
ment. Luteal support was provided by intramuscular pro-
gesterone (50 mg). Frozen embryos were cryopreserved at
either the pronuclear or blastocyst stage using a slow-
cooling protocol and subsequently thawed and transferred
in a hormonally programmed cycle utilizing increasing
doses of oral micronized estradiol (2–6 mg) followed
by intramuscular progesterone (25–50 mg) to induce
a receptive endometrium and to determine the timing
of transfer.
DNA preparation and bisulfite conversion
Placentas were collected at delivery and processed for
DNA analysis within 5 h as previously described [1, 20].
Briefly, placental tissue (1.5–2.5 cm3) was excised from
the fetal surface of the placenta, directly behind the cord
insertion site. The sample was rinsed extensively with
sterile saline solution to minimize maternal blood con-
tamination. The tissue was transferred to a 15-ml Falcon
tube for DNA extraction and initially stored at 4 °C; nu-
cleic acid extractions were performed within 2–4 days of
collection. Placenta genomic DNA was extracted using
standard phenol-chloroform extraction methods. The
isolated DNA was dissolved in TrisCl (10 mM, pH 8.0)
and stored at −80 °C until further use. Unmethylated
cytosine in genomic DNA (0.5–1 μg) was converted to
uracil by treatment with sodium bisulfite using the EZ
DNA Methylation KitTM (Zymo Research Corp., USA),
following the manufacturer’s guidelines. The bisulfite-
converted DNA was dissolved in 20-μl TrisCl (10 mM,
pH 8.0) buffer and stored at −20 °C until further use.
Luminometric methylation assay (LUMA)
Luminometric methylation assay (LUMA) was used to
estimate global methylation levels of placental samples
by sampling the fraction of the 2.3 million CCGG sites
that are methylated. The protocol has been described
previously [21]. We used a modification of this assay
[22]. In short, placental genomic DNA (300 ng) was sub-
jected to parallel digestions by methylation insensitive
restriction endonuclease (MspI), and its methylation sen-
sitive isoschizomer (HpaII) to produce 5′-CG overhangs.
EcoRI was used in both the reactions for normalization,
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thus, resulting in 5′AATT overhangs. The digested sam-
ples were pyrosequenced (PyroMark Q96 ID, Qiagen)
using the nucleotide dispensation order: GTGTCA-
CATGTGTG. The peak heights corresponding to HpaII
or MspI and EcoRI were then used to calculate the gen-
omic DNA methylation fraction using the formula 1-
[HpaII(G)/EcoRI(T)]/[MspI(G)/EcoRI(T)].
LINE1 methylation
Genomic DNA was treated with sodium bisulfite using
the EZ DNA methylation kit (Zymo Research). Bisulfite
converted DNA was amplified using primers and pyrose-
quenced as described previously [23]. LINE1 methylation
levels were estimated by taking the average of the first
three CpGs.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
(ver. 6.0 for Mac OS). Between-group differences in con-
tinuous data were analyzed using a two-tailed unpaired t
test for two groups and one-way ANOVA for more than
two groups. Tukey’s post hoc test was applied for mul-
tiple comparisons. Categorical data was analyzed using
Fisher’s exact test for 2 × 2 contingency tables and a chi-
square test for higher order contingency tables. Differ-
ences between males and females were analyzed using
one-tailed unpaired t test due to prior expectation [24]
for controls and singleton IVF; and one-tailed paired
t test for opposite sex twins.
Results
Sample characteristics
Placental samples from 259 singleton pregnancies (182
ART- and 77 in vivo-conceived-controls) were analyzed
by LUMA. High quality LINE1 pyrosequencing assay
data were also obtained for a subset of the 259 singleton
pregnancies (126 ART and 65 control placental samples).
Samples that did not pass pyrosequencing quality con-
trol (absent peaks or broad peaks) were not included for
LINE1 analysis. LINE1 pyrosequencing was also done in
the validation cohort (57 controls and 55 ART) and op-
posite sex twins (39 pairs). The demographic profile and
relevant clinical characteristics of all samples are shown
in Table 1.
The control and ART groups differed significantly in
both maternal and paternal age (p < 0.0001), with ART
parents being 3–4 years older. Given the significant dif-
ference in parental age, we stratified each population to
test for methylation differences associated with parental
age (Additional file 1), based on a prior definition of “ad-
vanced parental age” (>35 vs ≤35 years; [25]). We tested
four potentially modifiable clinical and laboratory factors
used in ART for an effect on methylation level (Table 1
and Additional file 2). These modifiable factors were as
follows: (1) mode of egg fertilization (ICSI or conven-
tional insemination); (2) oxygen tension during embryo
culture (20 or 5%); (3) type of embryo transfer (fresh or
frozen); (4) embryo transfer day (day 3 or day 5).
Surrogate measures of global methylation in ART vs
controls
The LUMA assay measures methylation level averaged
over 2.3 million CCGG sites (approximately 8% of the
28 million CpG sites in the human genome), and the
LINE1 assay measures average methylation levels at
three CpG sites in 516,000 copies of LINE1 elements
(approximately 5.5% of the CpG sites in the genome).
CCGG site methylation levels were significantly different
(p = 0.0002) between controls and ART (Fig. 1a and Table 2)
as were LINE1 element methylation levels (p = 0.0034)
(Fig. 1b and Table 3). Given these global differences
between the control and ART groups, we stratified
each group according to parental age and stratified
the ART group by four clinical/laboratory procedures
to determine whether differences were associated with
one or more of these factors.
Note on assay reproducibility and directional difference
between LUMA and LINE1 methylation levels
Though the absolute differences observed in methylation
between ART and control patients is small (Tables 2 and
3), the differences are highly statistically significant. In
addition, multiple studies, particularly from the oncology
literature, have shown a lack of correlation between
methylation levels measured by LUMA and LINE1 as-
says [26, 27]. This lack of correlation between the two
assays is likely due to the fact that they interrogate dif-
ferent compartments of the epigenome (see Discussion).
In terms of the reproducibility of the techniques, many
of the samples have been run multiple times. We have
calculated the standard deviation and also used Bland–
Altman plots to test for reproducibility. According to
Bland–Altman [28], if 95% of the samples are within the
limits of agreement then the assay is reproducible. In
our data, 96.5% of samples are within the limits for the
LUMA assay, and 100% of samples are in range for the
LINE1 assay.
Parental age
We divided the samples on the basis of maternal and pa-
ternal age (> or ≤35 years of age; Additional file 1). The
paternal age data were missing for some ART samples
where anonymous sperm donors were used (n = 7). In
the control group, paternal age data were missing for 14
samples. For both maternal and paternal age, global
methylation differences between ART and controls, as
measured by both LUMA and LINE1, were highly sig-
nificant in the younger parental age group (≤35 years),
Ghosh et al. Clinical Epigenetics  (2017) 9:14 Page 3 of 10
suggesting that the difference in methylation between
ART and control groups (Additional file 1) is not a result
of the older average age of ART patients. We did not
observe a significant difference in global methylation be-
tween ART and controls in the older parental age group
though the number of controls in this comparison was
small (LUMA: n = 22 for maternal age and n = 26 for pa-
ternal age; LINE1: n = 16 for maternal age and n = 21 for
paternal age) (Additional file 1).
Mode of egg fertilization
Nearly 30% of the ART samples resulted from eggs that
were fertilized using intra cytoplasmic sperm injection
(ICSI) (Table 1). We compared methylation of CCGG
sites in the placentas between ICSI and conventional in-
semination subgroups but did not observe any signifi-
cant differences (data not shown). On the other hand,
each subgroup was significantly different from controls
in methylation levels (p < 0.01). Overall, ANOVA indi-
cated that the three groups showed a significant differ-
ence in methylation levels (p = 0.0009) (Table 2).
Similarly, LINE1 methylation levels differed signifi-
cantly (p = 0.009) between the three groups (ICSI, con-
ventional insemination and controls). Furthermore, both
the ART subgroups showed significant difference from
the controls on post hoc analysis (Table 3).
Oxygen tension
The embryos in the ART group were cultured either at
atmospheric oxygen tension (20%) or physiological oxy-
gen tension (5%). Both oxygen tension ART groups differ
significantly in CCGG methylation levels from controls
(p < 0.01). ANOVA indicated a significant difference
between the groups (p = 0.0009) (Table 2). However,
samples from individuals cultured in 20% oxygen did
not differ from those cultured in 5% oxygen.
Fig. 1 Average global methylation fraction of placental samples in the original cohort: methylation fraction of CCGG sites using LUMA assay (a);
methylation fraction of LINE-1 elements using pyrosequencing assay (b)
Table 1 Demographic profile and clinical characteristics of the study subjects
Original cohort Validation cohort Twin cohort
ART (n = 182) Controls (n = 77) P value ART (n = 55) Controls (n = 57) P value ART (n = 39 pairs)
Maternal age (years, mean ± SD) 34.7 ± 3.6 32.2 ± 4.8 <0.0001a 35.8 ± 3.9 29.5 ± 6.1 <0.0001a 37.2 ± 5.2
Paternal age (years, mean ± SD) 36.9 ± 5.7 33.3 ± 5.2 <0.0001a 38.3 ± 6.5 34.8 ± 4.6 0.0610 39.0 ± 6.9
Mode of egg fertilization (ICSI/non ICSI) 54/127 NA – 30/23 NA – 14/24
Oxygen tension (20/5%) 123/59 NA – 16/38 NA – 19/19
Type of embryo transfer (fresh/frozen) 128/54 NA – 33/22 NA – 26/13
Embryo transfer day (day 3/day 5) 110/72 NA – 17/37 NA – 18/20
Gestational age (weeks, mean ± SD) 39.2 ± 1.3 39.1 ± 1.2 0.4306a 38.2 ± 3.6 38.2 ± 6.4 0.9990a 36.5 ± 2.1
Birth weight (grams, mean ± SD) 3441.5 ± 498.6 3318.8 ± 559.3 0.0837a 3196 ± 918.4 3411 ± 541.7 0.1324a 2653.1 ± 576.9
Males (%) 83(45.6) 39 (50.6) 0.4972b 26 29 0.7103b 39(50.0)
Females (%) 99(54.4) 38 (49.4) 29 28 39(50.0)
ART assisted reproductive technology; SD standard deviation;
ICSI intracytoplasmic sperm injection; NA not applicable
aUnpaired two-tailed t test
bFisher’s exact test
Values in italics denote significance
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The LINE1 methylation levels between the three
groups (5% oxygen tension, 20% oxygen tension, and
controls) also differed significantly (p = 0.0135). How-
ever, in this instance, the control group showed a signifi-
cant difference with the 20% oxygen group (p < 0.05) but
not the physiologic oxygen group (Table 3).
Type of embryo transfer
ART samples were stratified into fresh and frozen
subgroups.
Overall, these subgroups and controls have a signifi-
cant difference in CCGG methylation levels (p < 0.0001).
Post hoc analysis showed significant methylation dif-
ferences in both the ART groups compared to con-
trols (p < 0.05) (Table 2).
Similarly, we observed significant differences (p = 0.0137)
in LINE1 methylation levels between the three groups
(fresh, frozen, and controls) (Table 3). Furthermore, the
fresh group differed significantly from controls (p < 0.05)
but the frozen group did not.
Embryo transfer day
We analyzed global methylation levels based on the
stage at which the embryo was transferred back to the
uterus; cleavage stage (day 3) or blastocyst stage (day 5).
Again, these subgroups and controls were signifi-
cantly different in CCGG methylation levels (Table 2;
p = 0.0007), but these ART subgroups did not differ
significantly from each other (data not shown). However,
each of these subgroups had significantly different methy-
lation levels compared to controls (p < 0.05) (Table 2).
We found a significant difference in LINE1 methyla-
tion between controls, day 3 and day 5 embryo transfers
(p = 0.0137). On applying Tukey’s post hoc test, both the
embryo transfer subgroups showed significant methyla-
tion difference from the controls (p < 0.05) (Table 3).
Table 2 Luminometric methylation assay (LUMA)
Criteria for comparison Groups (n) Global methylation
fraction (mean ± SD)
P value
ANOVA Tukey’s post hoc test (vs controls)
Controls (77) 0.4827 ± 0.0723 – –
Total ART ART (182) 0.5182 ± 0.0670 – 0.0002a
Mode of egg fertilization ICSI (54) 0.5224 ± 0.0533 0.0009 <0.01
Non ICSI (127) 0.5158 ± 0.0720 <0.01
Oxygen tension 20%(123) 0.5176 ± 0.0689 0.0009 <0.01
5%(59) 0.5195 ± 0.0634 <0.01
Type of embryo transfer Fresh (128) 0.5109 ± 0.0684 <0.0001 <0.05
Frozen (54) 0.5357 ± 0.0608 <0.0001
Embryo transfer day Day 3 (110) 0.5212 ± 0.0689 0.0007 <0.001
Day 5 (72) 0.5138 ± 0.0643 <0.05
ANOVA analysis of variance; ART assisted reproductive technology; SD standard deviation; ICSI intracytoplasmic sperm injection
aUnpaired two-tailed t test
Values in italics denote significance
Table 3 LINE1 methylation pyrosequencing assay
Criteria for comparison Groups (n) Global methylation
fraction (mean ± SD)
P value
ANOVA Tukey’s post hoc test (vs controls)
Controls (65) 0.4997 ± 0.0463 – –
Total ART ART (126) 0.4789 ± 0.0459 – 0.0034a
Mode of egg fertilization ICSI (39) 0.4732 ± 0.0322 0.0090 <0.05
Non ICSI (87) 0.4815 ± 0.0508 <0.05
Oxygen tension 20%(73) 0.4781 ± 0.0526 0.0135 <0.05
5%(53) 0.4799 ± 0.0352 ns
Type of embryo transfer Fresh (90) 0.4784 ± 0.0487 0.0137 <0.05
Frozen (36) 0.4800 ± 0.0385 ns
Embryo transfer day Day 3 (67) 0.4783 ± 0.0529 0.0137 <0.05
Day 5 (59) 0.4796 ± 0.0463 <0.05
ANOVA analysis of variance; ART assisted reproductive technology; SD standard deviation; ICSI intracytoplasmic sperm injection; ns non significant
aUnpaired two-tailed t test
Values in italics denote significance
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Sex of newborns
Although there was no significant difference in the sex
ratio of ART vs control offspring, it is appropriate to ask
whether the methylation differences observed between
the ART and control groups are restricted to one sex be-
cause sex differences in both global and site-specific
methylation levels have been observed [24, 29–34].
Stratifying the samples according to sex demonstrates
that significant methylation differences are found in both
the female (p = 0.0226) and the male (p = 0.0030) sub-
groups for CCGG sites (Additional file 1). However,
LINE1 elements showed significant difference in methy-
lation levels only for the male (p = 0.0015) subgroup.
Furthermore, female ART placentas did not show sig-
nificant differences for any of the modifiable factors
(data not shown). On the other hand, both male ART
groups were significantly different (p < 0.05) from con-
trols based on the mode of egg fertilization and embryo
transfer day (Table 4). In addition, the 20% oxygen ten-
sion group (p < 0.01) and placentas from fresh embryo
transfer (p < 0.05) showed significantly different LINE1
methylation levels compared to the controls. Such differ-
ences were not evident for physiologic oxygen tension or
frozen embryo transferred groups (Table 4).
Sex differences
We observed methylation differences in LINE1 elements
between male and female controls (p = 0.0494). However,
ART placentas did not show (p = 0.4727) any sex-related
methylation differences (Table 5). We obtained similar
results in the validation cohort; sex-related differences
were observed in controls (p = 0.0078) but not in ART
placentas (p = 0.2149). The lack of a sex-difference
among the ART population was confirmed by examining
placentas from opposite sex twins (Table 5). The sex-
specific methylation differences observed in controls do
not appear among ART opposite sex twins (Table 5).
Discussion
We have observed that placentas from ART conceptions
differ from control placentas in DNA methylation levels,
whether examined CpG site-specifically [1, 35] or at
hundreds-of-thousands-to millions of sites, simultan-
eously (Fig. 1; Tables 2 and 3). Notably, both hypome-
thylation and hypermethylation of ART samples are
observed in both site-specific assays [1, 35] and at
multiple-interrogated sites in different sequence contexts
(Fig. 1; Tables 2 and 3). Given that the range of methyla-
tion values observed in ART and control populations
overlaps to a great degree (Fig. 1), one may legitimately
ask what is the source of the statistically significant dif-
ferences observed. Our hypothesis is that the differences
are due to a relatively small fraction of individuals in the
ART group who have highly disrupted, so-called “out-
lier”, DNA methylation levels at a significant fraction of
interrogated CpG sites [35]. We have observed that such
individuals are more prevalent in “low-birth-weight”
ART children [35] and multiple individuals who have
hypermethylation at CCGG sites, compared with the
most extreme controls, can be seen in Fig. 1a. An excess
of such outliers is less obvious for hypomethylation of
LINE1 elements (Fig. 1b) but there are, in fact, many
more ART individuals with LINE1 methylation values
less than 0.45 than control individuals.
Assisted reproductive technologies have been linked to
epigenetic disorders and adverse neonatal outcomes
[36, 37]. These anomalies may be the effect of paren-
tal factors (infertility or advanced age) [38], clinical
and laboratory procedures used in ART or both par-
ental factors and ART. We have observed that the
site-specific DNA methylation differences found in
autologous in vitro fertilized groups are also observed
in children conceived with the aid of donor oocytes
[10]. This observation suggests a role for ART proce-
dures in causing these discrepancies but does not
Table 4 LINE1 methylation pyrosequencing assay for males
Criteria for comparison Groups (n) Global methylation
fraction (mean ± SD)
P value
ANOVA Tukey’s post hoc test (vs controls)
Controls (33) 0.5091 ± 0.0463 – –
Mode of egg fertilization ICSI (19) 0.4739 ± 0.0339 0.0057 <0.05
Non ICSI (37) 0.4809 ± 0.0434 <0.05
Oxygen tension 20%(31) 0.4738 ± 0.0404 0.0044 <0.01
5%(25) 0.4843 ± 0.0399 ns
Type of embryo transfer Fresh (45) 0.4751 ± 0.0386 0.0033 <0.01
Frozen (11) 0.4924 ± 0.0457 ns
Embryo transfer day Day 3 (28) 0.4779 ± 0.0435 0.0067 <0.05
Day 5 (28) 0.4791 ± 0.0375 <0.05
ANOVA analysis of variance; SD standard deviation; ICSI intracytoplasmic sperm injection; ns non significant
Values in italics denote significance
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eliminate a role for parental factors. In addition to in-
fertility, the most distinguishing characteristic of par-
ents of ART children is older age. The present study
clearly demonstrates that the global methylation dif-
ferences between ART and control population are
present even among the offspring of younger parents
(≤35 years). This suggests that one or more of the in-
terventions involved in ART could be responsible for
these epigenetic differences, potentially leading to ad-
verse outcomes in ART-conceived children.
The clinically modifiable ART interventions, such as
superovulation, in vitro fertilization (conventional or
ICSI), embryo culture (in 5 or 20% O2), and embryo
transfer (cleavage or blastocyst stage), take place during
the preimplantation embryonic stage during a time of
extensive epigenetic reprogramming. We hypothesized
that some or all of these interventions might influence
the establishment and maintenance of epigenetic marks,
leading to abnormal DNA methylation levels.
While both CCGG site methylation and LINE1 methy-
lation differed between ART and control groups, only
LINE1 methylation discriminated between different ART
interventions. The reasons for this difference in discrim-
inatory power between surrogate global measures of
DNA methylation are unclear. CCGG sites are enriched
in hypomethylated CpG islands [39, 40], which are
found near the promoters of approximately half of all
genes, while LINE1 elements are dispersed in repeated
sequences that are generally hypermethylated [40]. ART
is associated with an increase in methylation in the usu-
ally hypomethylated CCGG site (Table 2) and a decrease
in methylation in the usually hypermethylated LINE1
sites (Table 3). In this regard, LINE1 elements are nor-
mally protected from the wave of genome-wide demeth-
ylation that occurs during preimplantation development
[41]. The maintenance of LINE1 elements in the methyl-
ated state in preimplantation embryos has been sug-
gested to suppress retrotransposition [23]. The fact that
ART placentas, overall, and each ART intervention, indi-
vidually, leads to lower levels of LINE1 methylation
(Table 3) suggest the possibility that ART interventions
may result in hypomethylation of some LINE1 elements
and a corresponding level of new LINE1 retrotransposi-
tions in the genome.
CCGG site methylation did not reveal any differences
among the different interventions, as both ART groups
within an intervention differ significantly from the
controls, without significant differences between the
interventions being compared. However, LINE1 methyla-
tion did show differences between the ART groups in
the oxygen tension of embryo culture and embryo
transfer type.
It has been argued earlier that embryo culture at
physiologic oxygen tension (5%) has a better success rate
[42]. Studies in mice have shown that 20% O2 delays oo-
cyte maturation, thereby impairing the development of
oocytes [43] and adversely affecting the developmental
potential of blastocysts [44]. Low concentrations of re-
active oxygen species have been observed in mouse em-
bryos cultured in 5% O2 compared to those from 20%
O2 [45]. In human IVF studies, physiologic oxygen con-
centration has been found to improve the blastulation
rate [46], blastocyst yield and embryo quality [47], and
increase live births [42]. Cochrane Database Review [48]
also supports the view that physiologic oxygen tension
has a better success rate. Our data (Table 3) also suggest
a detrimental effect of 20% oxygen over 5% oxygen ten-
sion on the epigenome, in comparison with controls, as
assayed by global LINE1 methylation.
Superovulation is an integral part of IVF procedure
wherein women undergoing IVF are administered ex-
ogenous gonadotropins to stimulate the production of
multiple follicles. This results in serum estradiol levels
10 times greater in a fresh IVF cycles than observed dur-
ing a natural cycle [49]. This hormonally imbalanced
uterine environment has been shown to affect embryo
implantation [50] and fetal growth [51] in mice. Frozen
embryo transfers (FET) have been found to overcome
these adverse effects of supraphysiologic hormonal levels
and improve endometrial receptivity [52]. A recent meta-
Table 5 Sex differences for LINE1 methylation pyrosequencing assay








fraction (mean ± SD)
Original cohort Controls 33 0.5091 ± 0.0463 32 0.4902 ± 0.0448 0.0494
ART 56 0.4785 ± 0.0402 70 0.4791 ± 0.0503 0.4727
Validation cohort Controls 29 0.4266 ± 0.0401 28 0.3936 ± 0.0583 0.0078
ART 26 0.4227 ± 0.0382 29 0.4386 ± 0.09538 0.2149
Opposite sex twins ART 39 0.4076 ± 0.0294 39 0.4098 ± 0.0320 0.3199
ART assisted reproductive technology; SD standard deviation
aUnpaired one-tailed t test
Values in italics denote significance [59]
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analysis of 13 cohort studies concluded that FET reduces
the risks of preterm birth and low birth weight [53].
At the expression level, frozen embryos showed more
consistent gene expression over morphologically matched
fresh embryos [54]. Our data suggests that global
methylation levels of frozen transfers are consistent
with the control group but these are significantly
variable for the fresh transfers.
The other interventions studied were the effects of
ICSI vs conventional IVF and day 3 vs day 5 of embryo
transfer. Our data are inconclusive on whether either
modification of either of these practices is less disruptive
to the epigenome. Others have found that ICSI is associ-
ated with more epigenetic alterations compared to con-
ventional IVF [55], but there is no clear indication as to
whether day 3 or day 5 embryo transfer is better. A re-
cent Cochrane Database Review found moderately high
clinical pregnancy and live birth rates in blastocyst fresh
transfers, but the data was inconclusive in regards to cu-
mulative live birth and pregnancy rates [56].
Our sex-stratified analysis suggests that sex of the
newborns could have a major role in influencing the ob-
served methylation differences between ART and control
placentas. In our study, CCGG methylation showed sig-
nificant differences for both male and female subgroups,
but the LINE1 methylation data showed differences in
male subgroups only. On further analysis based on the
modifiable factors, the males showed similar results as
observed in the combined analysis (males and females).
On the other hand, we did not see any differences in the
female group. This led us to investigate the methylation
difference between the sexes. We found significant
methylation difference between males and females in
controls, but this difference is not present in the ART
population. The absence of sex-influenced methylation
differences in ART was validated in an additional cohort
and in opposite sex twins conceived by ART.
There are reports showing that LINE1 methylation is in-
fluenced by sex [24, 57]. LINE1 hypomethylation in fe-
males was attributed to dietary differences and decreased
circulatory folate levels due to menstruation in these stud-
ies. However, it is unclear why this sex difference is not
evident in the ART children.
Males are more sensitive to maternal obesity induced in-
flammation [58], suggesting a greater impact of in utero
environment on male fetuses. Such a sex bias in sensitivity
to in utero environmental exposures could provide a pos-
sible explanation for the sex-specific effect of ART on ex-
punging male/female epigenetic differences that exist in in
vivo-conceived offspring. Further studies are needed to
evaluate these sex specific differences in depth.
There are limitations to this study. Clearly, other fac-
tors could be affecting DNA methylation, including cul-
ture media, response to superovulation, maternal BMI as
well as the many other unknown factors that might
affect the epigenome. In addition, long-term clinical sig-
nificance of these changes in global methylation must
still be investigated. However, these findings strengthen
previous data, from our group and others, that tech-
niques utilized during ART lead to changes in DNA
methylation.
Conclusions
We conclude that two clinically modifiable factors (5 vs
20% oxygen tension of embryo culture and fresh vs fro-
zen embryo transfer) are associated with global placental
methylation differences. In both interventions, the sub-
group associated with better clinical outcomes (5% O2
and frozen embryo transfer; [42–48, 52–54]) is also asso-
ciated with global DNA methylation levels that are
closer to those of children conceived in vivo. This sug-
gests not only that DNA methylation may be responsible
for (at least some) the adverse clinical outcomes associ-
ated with IVF, but that modification of our current prac-
tices may decrease the incidence of these adverse
outcomes. Further investigations correlating changes in
DNA methylation and adverse perinatal outcomes are
necessary to establish the protocols that can minimize
epigenetic changes following ART and reduce complica-
tions associated with IVF.
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